JAIC
HUMAW icon

Josh Arnold Investment Consultant’s Humacyte Inc Warrant HUMAW Stock Holding History

Josh Arnold Investment Consultant’s Portfolio HUMAW Stock Details HUMAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-259,974
Closed -$108K – 18
2023
Q4 		$108K Buy
259,974
+6,559
+3% +$3.22K 0.1% 21
2023
Q3 		$169K Sell
253,415
-16,585
-6% -$12.9K 0.18% 21
2023
Q2 		$197K Buy
+270,000
New +$218K 0.19% 21
2023
Q1 		– Sell
-237,693
Closed -$93K – 19
2022
Q4 		$93K Buy
+237,693
New +$210K 0.14% 18
2022
Q3 		– Sell
-194,718
Closed -$171K – 15
2022
Q2 		$171K Buy
+194,718
New +$299K 0.22% 17

Other funds holding HUMAW

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Josh Arnold Investment Consultant's HUMAW Position: Q1 2024 in Review

Josh Arnold Investment Consultant sold out of Humacyte Inc Warrant (HUMAW) in Q1 2024, closing a stake of 259,974 shares — an estimated $108K sold.

Josh Arnold Investment Consultant first reported a position in HUMAW in Q2 2022 and held it in 5 quarters. The position peaked at $197K in Q2 2023. 6 funds tracked by Wall St. Rank hold HUMAW as of Q1 2024.

  • Josh Arnold Investment Consultant reported no remaining Humacyte Inc Warrant position as of Q1 2024 after selling out during the quarter.
  • Josh Arnold Investment Consultant sold 259,974 Humacyte Inc Warrant shares in Q1 2024, an estimated $108K.
  • Josh Arnold Investment Consultant first reported a position in Humacyte Inc Warrant in Q2 2022 and held it in 5 quarters.
  • Josh Arnold Investment Consultant's Humacyte Inc Warrant position peaked at $197K in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q1 2024.

Based on Josh Arnold Investment Consultant's 13F filing for Q1 2024, filed 15 May 2024.